Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy
Clinical trial NCT04684511 · TERMINATED
Trial details
- NCT number
- NCT04684511
- Sponsor
- Tremeau Pharmceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-02
- Primary completion
- 2022-09-28
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.